Anti-CCL27 antibody [EPR8582(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal CCL27 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 7 publications.
View Alternative Names
ILC, SCYA27, CCL27, C-C motif chemokine 27, CC chemokine ILC, Cutaneous T-cell-attracting chemokine, ESkine, IL-11 R-alpha-locus chemokine, Skinkine, Small-inducible cytokine A27, CTACK
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CCL27 antibody [EPR8582(2)] (AB186421)
Immunofluorescent analysis of 4% paraformaldehyde-fixed A431 cells labeling CCL27 with ab186421 at 1/250 dilution followed by Goat anti rabbit IgG (Alexa Fluor® 555) secondary antibody at 1/200 dilution. Counter stained with Dapi.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CCL27 antibody [EPR8582(2)] (AB186421)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed HACAT cells labeling CCL27 with ab186421 at 1/320 dilution (red) compared to a Rabbit monoclonal IgG isotype control (green), followed by Goat anti rabbit IgG (FITC) secondary antibody at 1/150 dilution.
- WB
Supplier Data
Western blot - Anti-CCL27 antibody [EPR8582(2)] (AB186421)
All lanes:
Western blot - Anti-CCL27 antibody [EPR8582(2)] (ab186421) at 1/5000 dilution
All lanes:
Human CCL27 recombinant protein at 0.01 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 13 kDa
false
Related conjugates and formulations (1)
-
Anti-CCL27 antibody [EPR8582(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CCL27 attracts T cells to the skin's surface facilitating immune responses. Although not part of a larger complex CCL27 interacts with its receptor CCR10 on T cells directing them to skin sites where they can perform immune surveillance and respond to pathogens. This chemokine-receptor interaction is essential for maintaining skin homeostasis and effective immune responses.
Pathways
The role of CCL27 gets significant attention in the CCR10-CTACK axis which is pivotal in the cutaneous immune system's functioning. Additionally the CCL27/CCR10 pathway has connections to the wider chemokine signaling network that regulates leukocyte trafficking. Through these associations CCL27 is connected to other chemokines and receptors including CCL28 which also shares CCR10 as a receptor highlighting the integrated nature of chemokine function in immune pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:19950 PubMed40481048
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 17:5177-5195 PubMed39104909
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 36:e23213 PubMed36111657
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:756671 PubMed34899311
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 19:338 PubMed34372858
2021
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 22:52 PubMed33579290
2021
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 285:2278-2291 PubMed29676849
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com